Cornely OA, Duarte RF, Haider S, Chandrasekar P, Helfgott D, Jiménez JLópez, Candoni A, Raad I, Laverdiere M, Langston A, et al. Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. J Antimicrob Chemother. 2015.